sSMC derived from chromosome (1 or) 5 or 19  

Back to home

references of this sub-page

Cases without
clinical findings
3 Cases with
clinical findings
3
Cases with
unclear clinical correlation
 
In general 70% of sSMC carriers are clinically normal. The figures here are based partially on the bias, that mainly clinically aberrant cases are reported in literature!

Abbreviations and FISH-methods

 

_______________________________________________________________________________________

references of this sub-page

top of page

 

Cases without clinical findings (O):

case no. 

gender

age at diagnosis

studied 
material

de novo/ 
inherited

GTG-banding result
grade of mosaicism

final FISH result of the sSMC

FISH
methods

UPD
result

clinical symptoms

reference

05/19-O-p11/
1-1
female 36y PBL n.a. 47,XX,+mar[50%]/
46,XX[50%]
min(5)(:p11→q11.1:) or min(19)(:p11q12:) cenM, subcenM n.a. normal woman, unfulfilled wish for children {0} provided by Wagner, Stibbe, Hannover, Germany

O-cases with unclear/insufficient characterization of the sSMC itself (CO):

case no. 

gender

age at diagnosis

studied 
material

de novo/ 
inherited

GTG-banding result
grade of mosaicism

final FISH result of the sSMC

FISH
methods

UPD
result

clinical symptoms

reference

05/19-CO-1 female 1m PBL
cell line at ECACC DD0617
de novo 47,XX,+mar[50%]/
46,XX[50%]
in cell line no marker acc to {5}
mar(5 or 19) FISH with all available centromeric probes no UPD 5 or 19:
informative markers: D5S392; APOC2
clinically normal; studied due to failure to thrive, severe floppiness and pneumonia at 3w. {1} case 20
{3} case 10
{5} case 16}
05/19-CO-2 male prenatal AF de novo 47,XY,+mar[28]/
46,XY[22]
r(1 or 19) FISH with all available centromeric probes, telomeric probes n.a. Amniocentesis due to a Down syndrome risk of 1/170 on maternal serum triple marker screening, child born at 41 weeks gestation, and at three months of age was reported to be phenotypically normal. {4} case 5

references of this sub-page

top of page

_______________________________________________________________________________________

 

Cases with clinical findings (W):

case no. 

gender

age at diagnosis

studied 
material

de novo/ 
inherited

GTG-banding result
grade of mosaicism

final FISH result of the sSMC

FISH
methods

UPD
result

clinical symptoms

reference

05/19-W-1 male child PBL n.a. 47,XY+mar1[14]/ 47,XY,+mar2[2] min(1)(:p11→q11:) or min(5)(:p11→q11.1:) or min(19)(:p11→q11)
(mar2 is duplication of mar1)
cenM, subcenM, 1q12 n.a. hyperactivity, short stature, high arched palate. Long face. Short fingers. relatively large penis {0} provided by Dr. M. Sagai, Jerusalem, Israel

references of this sub-page

top of page

W-cases with unclear/insufficient characterization of the sSMC itself (CW):

case no. 

gender

age at diagnosis

studied 
material

de novo/ 
inherited

GTG-banding result
grade of mosaicism

final FISH result of the sSMC

FISH
methods

UPD
result

clinical symptoms

reference

05/19-CW-1 male

prenatal

CH/PBL de novo 47,XY,+mar1[27%]/
47,XY,+mar2[13%]/
47,XY,+mar3[20%]/
46,XY[40%]
(in CH mar in 60%; at birth mar in 60% of PBL; frequency given above is from 14m)
mar1 = min(5 or 19)
mar2 = dic(5 or 19)
mar3 = ?
FISH with all available centromeric probes n.a. Chorion biopsy due to advanced maternal age; at 14m large head (98. centile), frontal bossing, epicanthic folds, hypotonia, developmental delay. {3} case 11
05/19-CW-2 n.a.

prenatal

AF de novo 47,+mar[?%] r(1 or 5 or 19) n.a. n.a. cystic hygroma, TOP {7} 1 case

references of this sub-page

top of page

_______________________________________________________________________________________


Cases with unclear clinical correlation of the sSMC itself (U):

case no. 

gender

age at diagnosis

studied 
material

de novo/ 
inherited

GTG-banding result
grade of mosaicism

final FISH result of the sSMC

FISH
methods

UPD
result

clinical symptoms

reference

05/19-U-1 female 7y PBL
cell line at ECACC DD1145
de novo 47,XX,+mar[25]/
46,XX[9]
mar(5 or 19) FISH with all available centromeric probes no UPD 5 or 19:
informative markers: D5S392; APOC2
clinically normal according to {1}; large head, frontal bossing,  hypotonia, epicanthic folds, developmental delay, floppy according to ECACC {1} case 19
{2} case 22
05/19-U-2 female prenatal AF de novo 47,XX,+mar[80%]/
46,XX[20%]
min(1)(:p11→q11:) or min(5)(:p11→q11.1:) or min(19)(:p11→q11) cenM; subcenM no UPD 19:
informative markers: D19S1034, D19S245, D19S178,  D19S589, D19S254
amniocentesis due to advanced maternal age; no further information available {0} provided by Genteq, Hamburg, Germany
05/19-U-3 female prenatal AF de novo 47,XX,+mar[?100%] min(1)(:p11→q11:) or min(5)(:p11→q11.1:) or min(19)(:p11→q11) cenM; subcenM n.a. amniocentesis due to advanced maternal age; no US abnormalities. TOP. No dysmorphism in autopsy {0} provided by Dr. Bhatt, Sucheta, USA
05/19-U-4 to U5 n.a. n.a. n.a. n.a. 47,+mar[?%] mar(1/5/19) centromeric probes n.a. no info available {6}2 cases
05/19-U-6 moved to 19-U-17 {0} provided by Dr. Eiben, Oberhausen, Germany
05/19-U-7 female prenatal AF n.a. 47XX,+mar[27]/
46,XX[11]
min(5)(:p11→q11.1:) or min(19)(:p11→q12:) cenM; subcenM n.a. amniocentesis due to advanced maternal age; No further info available {0} provided by Dr. Mehnert, Neu-Ulm, Germany

references of this sub-page

top of page

_______________________________________________________________________________________